|
V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog
Scientific background:
Summary: The KRAS gene encodes an importent protein in signal transduction. In 17-25% of human tumor cells a somatic activating mutation can be found. These mutations make make the cell resistant to GTPase activating peptides.
Methodology:
|
clinical test |
Method |
Genomic sequencing of the entire coding region |
| Turn-around time |
20 working days |
| Effort |
little |
| Specimen |
DNA |
| Quality assessment |
Internal quality control only |
| |
All known and new missense, nonsense and splice mutations can be detected. |
|